- Home
- GRBK vs CRNX Comparison
GRBK vs CRNX Comparison
Compare GRBK & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRBK
- CRNX
- Stock Information
- Founded
- GRBK N/A
- CRNX 2008
- Country
- GRBK United States
- CRNX United States
- Employees
- GRBK N/A
- CRNX N/A
- Industry
- GRBK Homebuilding
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- GRBK Consumer Discretionary
- CRNX Health Care
- Exchange
- GRBK Nasdaq
- CRNX Nasdaq
- Market Cap
- GRBK 3.1B
- CRNX 2.8B
- IPO Year
- GRBK N/A
- CRNX 2018
- Fundamental
- Price
- GRBK $72.61
- CRNX $35.48
- Analyst Decision
- GRBK Buy
- CRNX Strong Buy
- Analyst Count
- GRBK 2
- CRNX 7
- Target Price
- GRBK $71.00
- CRNX $74.33
- AVG Volume (30 Days)
- GRBK 211.4K
- CRNX 1.2M
- Earning Date
- GRBK 10-29-2025
- CRNX 11-11-2025
- Dividend Yield
- GRBK N/A
- CRNX N/A
- EPS Growth
- GRBK 7.68
- CRNX N/A
- EPS
- GRBK 7.83
- CRNX N/A
- Revenue
- GRBK $2,137,742,000.00
- CRNX $1,392,000.00
- Revenue This Year
- GRBK N/A
- CRNX $489.51
- Revenue Next Year
- GRBK $6.60
- CRNX $661.93
- P/E Ratio
- GRBK $9.22
- CRNX N/A
- Revenue Growth
- GRBK 13.87
- CRNX 0.51
- 52 Week Low
- GRBK $50.57
- CRNX $24.10
- 52 Week High
- GRBK $84.66
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- GRBK 56.38
- CRNX 62.97
- Support Level
- GRBK $71.01
- CRNX $33.42
- Resistance Level
- GRBK $75.50
- CRNX $37.23
- Average True Range (ATR)
- GRBK 2.05
- CRNX 1.48
- MACD
- GRBK -0.20
- CRNX 0.03
- Stochastic Oscillator
- GRBK 59.92
- CRNX 74.93
About GRBK Green Brick Partners Inc.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.